The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation

Conditions:   Muscular Dystrophy, Duchenne;   DMD Intervention:   Drug: viltolarsen Sponsor:   NS Pharma, Inc. Available

Source: ClinicalTrials.gov - April 7, 2020 Category: Research Source Type: clinical trials